Reduce freezing with dynamic cycling
- Trial ID
- NCT05298150
- Official Title
- Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease
- Goal
- Reduce freezing with dynamic cycling
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- VA Office of Research and Development
- Study Type
- INTERVENTIONAL
- Enrollment
- 72 participants
- Conditions
- Parkinson's Disease
- Interventions
- Dynamic cycling, Forced cycling
Plain-Language Summary
The goal is to test whether remote dynamic or forced cycling can improve motor function and mobility in Parkinson's, especially slowness and walking difficulties. The approach uses a motor-assisted bicycle that moves your legs at a faster, steady cadence than you could produce on your own, a pattern thought to help retrain motor circuits and boost movement control, with sessions done off-site and monitored remotely. It is meant to be used alongside your usual Parkinson's medications, not as a replacement, so participants must be on a stable antiparkinsonian regimen for at least six months. The study is enrolling adults 18 and older with mild to moderate Parkinson's, Hoehn and Yahr stages I to III off medication, who have enough cognition to consent (MoCA 18 or higher) and no significant untreated cardiovascular issues, severe depression, anxiety, or atypical parkinsonism.
Locations
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Dynamic cycling. The goal is to test whether remote dynamic or forced cycling can improve motor function and mobility in Parkinson's, especially slowness and walking difficulties. The approach uses a motor-assisted bicycle that moves your legs at a faster, steady cadence than you could produce on your own, a pattern thought to help retrain motor circuits and boost movement control, with sessions done off-site and monitored remotely. It is meant to be used alongside your usual Parkinson's medications, not as a replacement, so participants must be on a stable antiparkinsonian regimen for at least six months. The study is enrolling adults 18 and older with mild to moderate Parkinson's, Hoehn and Yahr stages I to III off medication, who have enough cognition to consent (MoCA 18 or higher) and no significant untreated cardiovascular issues, severe depression, anxiety, or atypical parkinsonism.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 years.